But now, we have targeted therapeutic options such as 5-Amino1MQ to potentially help further inhibit NNMT to support healthier NAD+ levels
(AIs are established when there is insufficient information to determine EARs and RDAs.) For children ages 113 years, the RDA increases with age from 0.9 to 1.8 g/day
In rodent studies, NNMT inhibition was associated with shifts in metabolic substrate utilisation
will authorise the prescription
In neuronal senescence model studies, the active ingredient of the product can cross the blood-brain barrier (and act directly on neurons in vitro), increase NAD+ levels in nerve cells, protect mitochondrial function, reduce neuronal apoptosis, and promote the synthesis and release of neurotransmitters (such as dopamine and acetylcholine), thereby improving signal transduction in nerve cells
To learn more about how MOTS-C can help you, contact us to schedule a consultation